Physician

Bruce W. Fuller, M.D.

According to 2025 Medicare claims, Bruce Fuller, M.D. (NPI: 1588861397) practices dermatology in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is MOUNTAIN WEST DERM - BLACKHART PLLC (NPI: 1740633015; TIN: 813253496) and primary practice location at 89703-8457.

Fuller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,499 traditional Medicare patients, billed 11,485 HCPCS/CPT codes, and received $345,214 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 778 prescription claims across 345 beneficiaries totaling $127,955 in drug costs, led by Otezla (Apremilast). Open Payments data shows 58 records totaling $1,297. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $79,779 and ending at $127,955. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,323	11,051	$381,508
2016	1,240	11,096	$393,224
2017	740	4,772	$176,670
2018	603	5,162	$206,395
2019	638	4,876	$162,634
2020	1,389	11,074	$353,197
2021	1,482	10,698	$352,420
2022	1,542	10,710	$349,414
2023	1,721	11,896	$346,919
2024	1,499	11,485	$345,214

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	390	867	$79,779
2016	294	622	$60,597
2017	202	430	$32,230
2018	195	482	$20,236
2019	190	398	$15,155
2020	315	767	$114,604
2021	315	810	$108,595
2022	333	777	$73,285
2023	358	852	$80,202
2024	345	778	$127,955

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17004	Destruction of precancer skin growth, 15 or more growths	244	344	$113
11102	Biopsy of related skin growth, first growth	511	639	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,347	2,005	$58
17000	Destruction of precancer skin growth, 1 growth	929	1,289	$39
17003	Destruction of precancer skin growth, 2-14 growths	804	5,695	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	12	360	$28,943
Ketoconazole	Ketoconazole	117	3,521	$2,294
Metronidazole	Metronidazole	41	1,217	$2,178
Clobetasol Propionate	Clobetasol Propionate	47	1,385	$1,979
Triamcinolone Acetonide	Triamcinolone Acetonide	190	5,715	$1,834

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	58	$1,297	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bruce W. Fuller, M.D.?

Tedicare shows public-source Medicare data for Bruce W. Fuller, M.D. (NPI 1588861397), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bruce W. Fuller, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bruce W. Fuller, M.D.?

Bruce W. Fuller, M.D. is linked to MOUNTAIN WEST DERM - BLACKHART PLLC (billing NPI 1740633015) in the available physician profile data.

Does Bruce W. Fuller, M.D. have Open Payments data?

Bruce W. Fuller, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.